Company Filing History:
2 out of 5,309 
1 out of 25 
3 out of 832,843 Years Active: 2001-2005
Title: Glenn D. Rosen: Innovator in Anti-Proliferative Therapies
Introduction
Glenn D. Rosen is a notable inventor based in Stanford, California, recognized for his contributions to the field of anti-proliferative agents. With a total of five patents to his name, he has made significant strides in developing therapies aimed at treating hyperproliferative disorders.
Latest Patents
Among his latest patents, one focuses on the uses of diterpenoid triepoxides as an anti-proliferative agent. This patent details how combinations of diterpenoid triepoxides and anti-proliferative agents can be utilized in combination therapy to effectively treat hyperproliferative disorders. The anti-proliferative agents of interest include those that are effective in killing tumor cells, immunosuppressants, and various other agents that reduce cellular proliferation in targeted tissues. The synergistic combinations outlined in his patent provide comparable or improved therapeutic effects while minimizing adverse side effects.
Career Highlights
Throughout his career, Glenn D. Rosen has worked at Leland Stanford Junior University, where he has contributed to research and development in his field. His innovative work has led to advancements in therapeutic strategies that address critical health issues.
Collaborations
Glenn has collaborated with esteemed colleagues such as Edwin S. Lennox and John H. Musser, further enhancing the impact of his research and inventions.
Conclusion
Glenn D. Rosen's work in the realm of anti-proliferative therapies showcases his dedication to improving treatment options for hyperproliferative disorders. His innovative patents and collaborations highlight his significant contributions to medical science.